Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Shircore
T Garrison

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
ACS Chemical Neuroscience|July 4, 2019
Acute Negative Allosteric Modulation of M<sub>5</sub> Muscarinic Acetylcholine Receptors Inhibits Oxycodone Self-Administration and Cue-Induced Reactivity with No Effect on AntinociceptionRobert W Gould, Barak W Gunter, Michael Bubser, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2001
2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amidesM J Bishop, J Berman, E C Bigham, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolinesMichael J Bishop, Kevin A Barvian, Judd Berman, et al.
Journal of Combinatorial Chemistry|March 11, 2003
High-throughput manual parallel synthesis using SynPhase crowns and lanternsSamuel W Gerritz, Mark H Norman, Lee A Barger, et al.
Journal of Medicinal Chemistry|October 17, 2025
Optimization of Selective and CNS Penetrant Alkyne-Based TREK Inhibitors: The Discovery and Characterization of ONO-9517601 (VU6022856) and ONO-7927846 (VU6024391)Motoyuki Tanaka, Yoko Sekioka, Gakuji Hashimoto, et al.
Journal of Medicinal Chemistry|April 13, 2022
Development of <b>VU6019650</b>: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M<sub>5</sub> Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use DisorderAaron T Garrison, Douglas L Orsi, Rory A Capstick, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
ACS Chemical Neuroscience|July 4, 2019
Acute Negative Allosteric Modulation of M<sub>5</sub> Muscarinic Acetylcholine Receptors Inhibits Oxycodone Self-Administration and Cue-Induced Reactivity with No Effect on AntinociceptionRobert W Gould, Barak W Gunter, Michael Bubser, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2001
2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amidesM J Bishop, J Berman, E C Bigham, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolinesMichael J Bishop, Kevin A Barvian, Judd Berman, et al.
Journal of Combinatorial Chemistry|March 11, 2003
High-throughput manual parallel synthesis using SynPhase crowns and lanternsSamuel W Gerritz, Mark H Norman, Lee A Barger, et al.
Journal of Medicinal Chemistry|October 17, 2025
Optimization of Selective and CNS Penetrant Alkyne-Based TREK Inhibitors: The Discovery and Characterization of ONO-9517601 (VU6022856) and ONO-7927846 (VU6024391)Motoyuki Tanaka, Yoko Sekioka, Gakuji Hashimoto, et al.
Journal of Medicinal Chemistry|April 13, 2022
Development of <b>VU6019650</b>: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M<sub>5</sub> Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use DisorderAaron T Garrison, Douglas L Orsi, Rory A Capstick, et al.
Pageof 6